Weekly Newsletter

Thursday, January 29, 2026

News

Covid Infection Raises Heart Inflammation Risk in Kids More Than Vaccines

Massive England study finds myocarditis and pericarditis were rarer and shorter after immunisation than after Covid infection. Cambridge, England, 19 January 2026 - Health misinformation remains one of Covid’s most damaging legacies, fuelling vaccine hesitancy and weakening trust in public...

Rising Health Insurance Costs Hit Millions After ACA Subsidies Expire

End of enhanced tax credits leads to sharp premium increases for self-employed and middle-class Americans Washington, D.C., US, 2 January 2026 – Millions of Americans are starting the new year facing significantly higher health insurance costs after enhanced Affordable Care...

Metabolic Syndrome Remains Widespread Across the US, New Study Finds

JAMA research shows nearly four in ten American adults live with clustered heart risk factors, with older adults most affected Washington, D.C., United States, 15 December 2025 – Metabolic syndrome continues to affect a large share of the adult population...

Genetix Biotherapeutics Earns Spotlight at ASH 2025 for Breakthrough Progress in Gene Therapy Adoption

Exclusive press program selection highlights growing patient access to one-time treatments for sickle cell disease and transfusion-dependent thalassemia. Somerville, Massachusetts, 4 December 2025 – Genetix Biotherapeutics Inc. has been selected to participate in the American Society of Hematology’s (ASH) exclusive...

Innovators

Insights

The Importance of Clear Communication in Patient Monitoring Technologies

Patient monitoring systems have become an important tool to improve healthcare. The advancement of technologies allows to perform activities that were unthinkable till recently. Remote data access allows health care professionals to closely monitor patients and react in real-time. These...

Monitoring for adverse reactions with GLP-1 agonists

The recent uptick of prescribing glucagon-like peptide 1 (GLP-1) agonists has created market shortages due to unprecedented demands. Liraglutide, dulaglutide, tirzepatide and semaglutide are indicated to improve glycemic control in type 2 diabetes mellitus. In addition, tirzepatide and semaglutide...

How Tech-Enabled Remote Patient Monitoring is Transforming Care Delivery Across the Continuum

Twenty years ago, when we founded our healthcare IT-focused public relations and marketing firm, patient monitoring did not typically leave the four walls of the hospital. Our clients at the time were among the first to design software and...

A new era for the medical sector in 2030

The health sector has always been primordial to me. Not only because it is more than essential, vital for human beings, but also because many economic, societal and technological challenges of the future arise directly from this area. Which...